Epilepsy study: 2-phenylethanol rose scent
Official title Effect of Rose Odor Exposure on Ictal Apnea
ClinicalTrials.gov ID: NCT07116421
What this study is testing
What is 2-phenylethanol rose scent?
This is an investigational rose scent being studied to see if it might help reduce the risk of sudden unexpected death in epilepsy.
Also referred to as Rose aromatherapy, Rose smell, Rose oil, Rose diffusor scent.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to see if smelling rose scent for 24 hours reduces breathing problems that might lead to sudden unexpected death in epilepsy (SUDEP).
- Who it's for
- People with epilepsy who are staying in the hospital’s epilepsy monitoring unit.
- What's involved
- Participants will have their normal 24‑hour EEG monitoring, then another 24‑hour period with a rose‑scent diffuser in the room while wearing a chest belt that tracks breathing.
- Time commitment
- A total of 48 consecutive hours during the hospital stay, with most of that time wearing the breathing belt.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult epilepsy patients over the age of 18
- Admission to the inpatient epilepsy monitoring unit (EMU) at Vanderbilt University Medical Center (VUMC)
- Undergoing observational EEG monitoring without treatment involving seizure medication changes or other interventions for at least 48 hours
You likely can't join if
- Patients under the age of 18
- Patients receiving EEG monitoring without interventions from baseline for less than 48 hours
- Patients who are not receiving EEG monitoring as a part of their inpatient admission.
The study team makes the final eligibility decision.
Where it is enrolling
- Nashville, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Nashville, Tennessee, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.